Evidence map›Paper›PMID 31155927›Full record

ArticleExperimental biology and medicine (Maywood, N.J.)2019

Downregulation of WW domain-containing oxidoreductase leads to tamoxifen-resistance by the inactivation of Hippo signaling.

Juan Li, Xuefei Feng, Canyu Li, Jie Liu, Pingping Li, Ruiqi Wang, He Chen, Peijun Liu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Experimental biology and medicine (Maywood, N.J.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Juan Li1 Center for Translational Medicine, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, PR China.ORCID 0000-0003-0529-387X
Xuefei Feng1 Center for Translational Medicine, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, PR China.
Canyu Li3 Health science center, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, PR China.
Jie Liu1 Center for Translational Medicine, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, PR China.
Pingping Li1 Center for Translational Medicine, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, PR China.
Ruiqi Wang1 Center for Translational Medicine, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, PR China.
He Chen1 Center for Translational Medicine, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, PR China.
Peijun Liu1 Center for Translational Medicine, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, PR China.ORCID 0000-0002-3910-1410

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Drug Resistance, NeoplasmActive Transport, Cell NucleusAdaptor Proteins, Signal TransducingBreast NeoplasmsCell NucleusFemaleHippo Signaling PathwayHumansMCF-7 CellsPhosphorylationProtein Serine-Threonine KinasesTamoxifenTranscription FactorsTumor Suppressor ProteinsWW Domain-Containing OxidoreductaseYAP-Signaling ProteinsAdaptor Proteins, Signal TransducingProtein Serine-Threonine KinasesTamoxifenTranscription FactorsTumor Suppressor ProteinsWW Domain-Containing OxidoreductaseWWOX protein, humanYAP1 protein, humanYAP-Signaling ProteinsBreast cancercellHipporesistancetamoxifenWW domain-containing oxidoreductase

Identifiers

PMID31155927
PMCPMC6879770

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.